Ubs Global Asset Management Americas »

Lyell Immunopharma shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $74k 33k 2.23
2023-12-31 $64k 33k 1.94
2023-09-30 $49k 33k 1.47

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Nvidia Corp Equity Us Cm (NVDA)
Amazon Equity Us Cm (AMZN)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Meta Platforms Equity Us Cm (META)
Ishares Core Msci Eafe Equity (IEFA)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Eli Lilly &#38 Equity Us Cm (LLY)
Broadcom Equity Us Cm (AVGO)
Tesla Equity Us Cm (TSLA)
Unitedhealth Group Equity Us Cm (UNH)
Advanced Micro Devices Equity Us Cm (AMD)
Visa Inc Class A Shares Equity Us Cm (V)
Jpmorgan Chase &#38 Company Equity Us Cm (JPM)

View all positions for Ubs Global Asset Management Americas

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
T. Rowe Price Associates
Alphabet
Geode Capital Management
Opaleye Management
Sc China Holding
FMR
Millennium Management
MIC Capital Management UK
Massachusetts Financial Services
Northern Trust
Charles Schwab Investment Management

View all funds holding Lyell Immunopharma